Researchers have been excited about this new drug, a groundbreaking dual agonist showing remarkable results in early trials for body loss . It acts by impacting both hormones : GLP-1 and GIP, which , when engaged , help influence cravings and improve energy expenditure . Initial reports demonstrate substantial weight management and possible advanta